Law.com Subscribers SAVE 30%
Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Canadian Pharmaceutical Agency Wants Ban on Exports to U.S.
The Canadian National Association of Pharmacy Regulatory Authorities (NAPRA), Canada's voluntary umbrella association of provincial and territorial pharmacy licensing bodies, has asked the Canadian government to legislate against the export of drug products to the United States. In a press release issued by NAPRA November 13, the organization noted that such exports are creating a challenge for those pledged to protecting Canadian public safety, and placed much of the blame for the problem on American agencies' failure to enforce U.S. laws. “The [Canadian] federal and provincial regulatory systems … were not originally designed to regulate the export of prescription drugs. Provincial self-regulation of the profession of pharmacy and the distribution of drugs is intended to protect Canadians. Similarly, the federal drug approval process is designed so that Canadians will have safe and effective access to drugs,” the release stated.
NAPRA criticized other, unnamed, Canadian government agencies – presumably governmental bodies in those provinces that are taking the greatest advantage of the demand – that encourage the export of drugs to other countries for the purpose of increasing regional economic growth. This practice, NAPRA claims, conflicts with the national public policy of providing Canadians with access to pharmaceutical products. NAPRA's statement warns that because of the conflict resulting from these competing objectives, those government agencies responsible for promoting export of Canadian drugs in order to boost local economies “must also be responsible for the consequences.” These consequences so far have included moves by pharmaceutical companies to raise prices in Canada, as well as to cut off or limit sales to Canadian pharmaceutical distributors.
The Canadian National Association of Pharmacy Regulatory Authorities (NAPRA), Canada's voluntary umbrella association of provincial and territorial pharmacy licensing bodies, has asked the Canadian government to legislate against the export of drug products to the United States. In a press release issued by NAPRA November 13, the organization noted that such exports are creating a challenge for those pledged to protecting Canadian public safety, and placed much of the blame for the problem on American agencies' failure to enforce U.S. laws. “The [Canadian] federal and provincial regulatory systems … were not originally designed to regulate the export of prescription drugs. Provincial self-regulation of the profession of pharmacy and the distribution of drugs is intended to protect Canadians. Similarly, the federal drug approval process is designed so that Canadians will have safe and effective access to drugs,” the release stated.
Major Differences In UK, U.S. Copyright Laws
This article highlights how copyright law in the United Kingdom differs from U.S. copyright law, and points out differences that may be crucial to entertainment and media businesses familiar with U.S law that are interested in operating in the United Kingdom or under UK law. The article also briefly addresses contrasts in UK and U.S. trademark law.
Strategy vs. Tactics: Two Sides of a Difficult Coin
With each successive large-scale cyber attack, it is slowly becoming clear that ransomware attacks are targeting the critical infrastructure of the most powerful country on the planet. Understanding the strategy, and tactics of our opponents, as well as the strategy and the tactics we implement as a response are vital to victory.
The Article 8 Opt In
The Article 8 opt-in election adds an additional layer of complexity to the already labyrinthine rules governing perfection of security interests under the UCC. A lender that is unaware of the nuances created by the opt in (may find its security interest vulnerable to being primed by another party that has taken steps to perfect in a superior manner under the circumstances.
Removing Restrictive Covenants In New York
In Rockwell v. Despart, the New York Supreme Court, Third Department, recently revisited a recurring question: When may a landowner seek judicial removal of a covenant restricting use of her land?